Johnson & Johnson News Headlines

JNJ 
$102.69
*  
1.04
1.02%
Get JNJ Alerts
*Delayed - data as of Mar. 5, 2015 10:33 ET  -  Find a broker to begin trading JNJ now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    JNJ Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Can Albert Einstein's Math Get You To The Finish Line? Retirement Portfolio Quarterly Review
12/4/2014 3:57:00 PM - Seeking Alpha


Will MedTech Gain from Republican Promises? - Industry Outlook
12/4/2014 1:00:00 PM - Investopedia


Stryker (SYK) Rewards Shareholders with 13% Dividend Hike - Analyst Blog
12/4/2014 12:30:00 PM - Zacks.com


Why Biotech Stocks Don't Pay Dividends
12/4/2014 9:13:02 AM - Motley Fool


Johnson & Johnson Bought Alios for Hepatitis C
12/4/2014 8:21:02 AM - Motley Fool


The Million-Dollar Retirement Portfolio: 6-Month Follow-Up
12/3/2014 9:52:00 PM - Seeking Alpha


Third Quarter Earnings Season In Review: Sector Winners And Losers, The Misleading 'Record' Beat Rate And The Outlook For Q4
12/3/2014 5:50:00 PM - Seeking Alpha


Pain Therapeutics' Remoxy Would Be A Good Fit For Any Of These Experienced Companies
12/3/2014 3:41:00 PM - Seeking Alpha


Noteworthy ETF Inflows: IWD, JNJ, PG, CVX
12/3/2014 10:54:14 AM - BNK Invest


BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotech Revolution?
12/3/2014 10:51:00 AM - Seeking Alpha


Risk Factors For The U.S. Economy In 2015
12/3/2014 9:46:00 AM - Seeking Alpha


Grifols, S.A. (GRFS) Ex-Dividend Date Scheduled for December 04, 2014
12/3/2014 9:00:01 AM - NASDAQ.com News


3 Reasons I Prefer Dividend Growth Investing
12/3/2014 8:01:00 AM - Seeking Alpha


Pharmacyclics, J&J Seek Imbruvica Label Expansion in EU - Analyst Blog
12/2/2014 6:05:00 PM - Zacks.com


Why Geron Corporation Stock Surged 65% in November
12/2/2014 12:30:11 PM - Motley Fool


Equity Investing Or Index Investing
12/2/2014 3:20:00 AM - Seeking Alpha


My Strategy For Objective, Emotionless Dividend Growth Investing, Part 2
12/1/2014 1:51:00 PM - Seeking Alpha


Stryker Grows on Strategic Buyouts, Competition Rampant - Analyst Blog
12/1/2014 12:40:00 PM - Zacks.com


3 Healthcare Stocks to Hold Forever
12/1/2014 11:45:02 AM - Motley Fool


Billionaires are Dumping These 3 Stocks
12/1/2014 9:30:03 AM - Motley Fool


Up 31% in 2014, is Pharmacyclics Stock Still a Buy?
12/1/2014 9:15:02 AM - Motley Fool


Retirement Strategy: The 'Buy The Dips Portfolio' Continues To Exceed Our Expectations
12/1/2014 12:01:00 AM - Seeking Alpha


Retirement Portfolio For Dummies - The Health Care Components
11/30/2014 1:42:00 PM - Seeking Alpha


3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015
11/29/2014 2:01:03 PM - Motley Fool


AstraZeneca/Amgen's Brodalumab Excels in Psoriasis Study - Analyst Blog
11/26/2014 5:30:00 PM - Zacks.com